---
title: "If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295859295.md"
description: "Axsome Therapeutics (NASDAQ:AXSM) has significantly outperformed the market over the past decade, achieving an annualized return of 40.19%. An initial investment of $100 ten years ago would now be worth approximately $2,919.13, highlighting the power of compounded returns. The company currently holds a market capitalization of $11.19 billion."
datetime: "2026-08-13T23:00:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295859295.md)
  - [en](https://longbridge.com/en/news/295859295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295859295.md)
---

# If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 10 years by 26.64% on an annualized basis producing an average annual return of 40.19%. Currently, Axsome Therapeutics has a market capitalization of $11.19 billion.

**Buying $100 In AXSM:** If an investor had bought $100 of AXSM stock 10 years ago, it would be worth **$2,919.13** today based on a price of $213.68 for AXSM at the time of writing.

### Axsome Therapeutics’s Performance Over Last 10 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/13/0e2adf30512de3eda95b14a713282bdb.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [AXSM.US](https://longbridge.com/en/quote/AXSM.US.md)

## Related News & Research

- [Pallas Capital Advisors LLC Acquires Shares of 40,511 Axsome Therapeutics, Inc. $AXSM](https://longbridge.com/en/news/296210947.md)
- [Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results](https://longbridge.com/en/news/295552524.md)
- [Axsome Therapeutics (AXSM) Stock Looks Near Fair Value Despite Premium Sales Pricing](https://longbridge.com/en/news/295177876.md)
- [Axsome Therapeutics (AXSM) to Announce Earnings on Monday](https://longbridge.com/en/news/294646650.md)
- [Healthcare of Ontario Pension Plan Trust Fund Invests $16.49 Million in Axsome Therapeutics, Inc. $AXSM](https://longbridge.com/en/news/294039544.md)